Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif.

Slides:

Advertisements

Similar presentations

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Mian Xi, MD, Zhongxing.

Advertisements

Su K. Metcalfe, MD, MPH, Michael T

Neoplastic Fever Caused by Lung Cancer

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Tumor angiogenesis in predicting the survival of patients with stage I lung cancer Baris Medetoglu, MD, Mehmet Zeki Gunluoglu, MD, Adalet Demir, MD, Huseyin.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus Yang Zhao, MD, ZhiJun Dai,

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Neoadjuvant Chemotherapy for Stage III and IVA Thymomas: A Single-Institution Experience with a Long Follow-up Marco Lucchi, MD, Franca Melfi, MD, Paolo.

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Surgical Treatment in Patient with Non–Small-Cell Lung Cancer with Fissure Involvement: Anatomical versus Nonanatomical Resection Giovanni Leuzzi, MD,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Complement and Correction for Meta-Analysis of Patients with Extensive-Stage Small Cell Lung Cancer Managed with Irinotecan/Cisplatin versus Etoposide/Cisplatin.

Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer Masatsugu Hamaji,

Surgical Treatment for Octogenarians with Lung Cancer: Results from a Population- Based Series of 124 Patients Hes A.P. Brokx, MD, Otto Visser, MD, PhD,

Hironori Yoshida, MD, Young Hak Kim, MD Journal of Thoracic Oncology

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao,

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Thymoma—A Clinico-Pathological Long-Term Study with Emphasis on Histology and Adjuvant Radiotherapy Dose Thomas Harnath, MD, Alexander Marx, MD, Philipp.

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Effect of Chemotherapy in Patients With Resected Small-Cell or Large-Cell Neuroendocrine Carcinoma Nader Abedallaa, MD, Lise Tremblay, MD, Charlotte.

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

Neoplastic Fever Caused by Lung Cancer

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Tamas F. Molnar, Cengiz Gebitekin, Akif Turna

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Yang Zhang, MD, Haiquan Chen, MD, PhD

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Jeffrey T. Yorio, MD, Yang Xie, PhD, Jingsheng Yan, PhD, David E

Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database

Daniel Morgensztern, MD, Boone Goodgame, MD, Maria Q

Erratum Journal of Thoracic Oncology

Outcomes of Mediastinoscopy and Surgery with or without Neoadjuvant Therapy in Patients with Non-small Cell Lung Cancer Who are N2 Negative on Positron.

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Dose-per-Fraction Escalation of Accelerated Hypofractionated Three-Dimensional Conformal Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Role of Postoperative Radiotherapy in Nonlocalized Thymoma

It’s All in the “Swerve of the Curve”

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

Immune-Modulating Vaccines in Non-small Cell Lung Cancer

A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Mian Xi, MD, Zhongxing.

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Pulmonary Resection for Metastases from Colorectal Cancer

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Video-assisted mediastinoscopic lymphadenectomy is associated with better survival than mediastinoscopy in patients with resected non–small cell lung.

International Thymic Malignancies Interest Group: A Way Forward

Primary Small Cell Carcinoma of the Esophagus

Outcome of Multimodality Treatment for 188 Cases of Type B3 Thymoma

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Tumor Lysis Syndrome in Limited-Stage Small-Cell Lung Cancer

Single-Institution, Multidisciplinary Experience with Surgical Resection of Primary Chest Wall Sarcomas Puja Kachroo, MD, Peter S. Pak, MD, Harpavan.

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

APLCC POSTER SESSION 2 - WEDNESDAY, NOVEMBER 28

Disease-Free Interval Length Correlates to Prognosis of Patients Who Underwent Metastasectomy for Esophageal Lung Metastases Satoshi Shiono, MD, Masafumi.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Razvan Diaconescu, MD, Chantal Lafond, MD, Renaud Whittom, MD

Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues” Boris Sepesi,

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the Thorax Adalet Demir, MD, Mehmet Zeki Gunluoglu, MD, Nergiz Dagoglu, MD, Akif Turna, MD, FETCS, PhD, Yavuz Dizdar, MD, Kamil Kaynak, MD, FETCS, Sukru Dilege, MD, Nil Molinas Mandel, MD, Dilek Yilmazbayhan, MD, Seyyit Ibrahim Dincer, MD, Atilla Gurses, MD Journal of Thoracic Oncology Volume 4, Issue 2, Pages 185-192 (February 2009) DOI: 10.1097/JTO.0b013e318194fafe Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 A, Chest magnetic resonance image of a patient showing a thoracic mass that was confirmed to be a PNET (primitive neuroectodermal tumor). B, Chest computerized tomography image of the same patient taken after neoadjuvant chemotherapy showing total regression. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Overall survival curve of the patients who underwent surgical resection only. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Disease -free survival curve of the patients who underwent surgical resection only. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Survival curves based on tumor location. TW, Thoracic wall; TW + CVJ, Thoracic wall with costovertebral junction involvement. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 5 Patient survival according to the method of control: chemotherapy (±radiotherapy) and surgery (CT(±RT)+S) versus surgery (S) alone. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 6 Disease-free survival of patients according to the method of control: chemotherapy (±radiotherapy) and surgery (CT(±RT)+S) versus surgery (S) alone. Journal of Thoracic Oncology 2009 4, 185-192DOI: (10.1097/JTO.0b013e318194fafe) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions